{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:34:24Z","timestamp":1793313264805,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejpb.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T23:48:12Z","timestamp":1434066492000},"page":"312-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy"],"prefix":"10.1016","volume":"94","author":[{"given":"Kuan-Hui","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca E.","family":"Carbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2015.06.001_b0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Brit. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0010","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"B. World Health Organ."},{"key":"10.1016\/j.ejpb.2015.06.001_b0015","unstructured":"NEI, Report of the Glaucoma Panel, Fall, 1998. <http:\/\/www.nei.nih.gov\/resources\/strategicplans\/neiplan\/frm_glaucoma.asp> (accessed 20.08.14)."},{"key":"10.1016\/j.ejpb.2015.06.001_b0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2014recent advances","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2015.06.001_b0025","first-page":"1","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2015.06.001_b0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","article-title":"Treatment for glaucoma: adherence by the elderly","volume":"83","author":"Gurwitz","year":"1993","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ejpb.2015.06.001_b0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","article-title":"Patient-reported behavior and problems in using glaucoma medications","volume":"113","author":"Sleath","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.06.001_b0040","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"Tsai","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.06.001_b0045","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ejpb.2015.06.001_b0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004397-198002030-00004","article-title":"Structures and fluids involved in the penetration of topically applied drugs","volume":"20","author":"Maurice","year":"1980","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.ejpb.2015.06.001_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00124-8","article-title":"In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials","volume":"257","author":"Karlgard","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.06.001_b0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICL.0b013e3181b26c49","article-title":"Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses","volume":"35","author":"Boone","year":"2009","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ejpb.2015.06.001_b0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425247.2013.821462","article-title":"Contact lenses as a platform for ocular drug delivery","volume":"10","author":"Bengani","year":"2013","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.ejpb.2015.06.001_b0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00137696-200604030-00002","article-title":"Contact lenses for drug delivery","volume":"4","author":"Alvarez-Lorenzo","year":"2006","journal-title":"Am. J. Drug Del."},{"key":"10.1016\/j.ejpb.2015.06.001_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clae.2007.09.002","article-title":"Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review","volume":"31","author":"Xinming","year":"2008","journal-title":"Cont. Lens Anterior Eye"},{"key":"10.1016\/j.ejpb.2015.06.001_b0080","article-title":"Review of ophthalmic drug delivery by contact lenses","volume":"24","author":"Hsu","year":"2014","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0085","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.biomaterials.2010.01.113","article-title":"Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers","volume":"31","author":"Peng","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.06.001_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2010.07.119","article-title":"Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E","volume":"148","author":"Kim","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.06.001_b0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/02713683.2011.630154","article-title":"Drug delivery by contact lens in spontaneously glaucomatous dogs","volume":"37","author":"Peng","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2015.06.001_b0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","article-title":"Extended drug delivery by contact lenses for glaucoma therapy","volume":"162","author":"Peng","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.06.001_b0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2011.06.028","article-title":"Extended cyclosporine delivery by silicone-hydrogel contact lenses","volume":"154","author":"Peng","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.06.001_b0110","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/la203606z","article-title":"Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses","volume":"28","author":"Peng","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2015.06.001_b0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejpb.2013.04.017","article-title":"Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone-hydrogel contact lenses","volume":"85","author":"Hsu","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.06.001_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/02713683.2014.917192","article-title":"Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses","volume":"40","author":"Hsu","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2015.06.001_b0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2165\/00002512-200623120-00005","article-title":"Topical dorzolamide 2%\/timolol 0.5% ophthalmic solution","volume":"23","author":"Frampton","year":"2006","journal-title":"Drug Aging"},{"key":"10.1016\/j.ejpb.2015.06.001_b0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1463-5224.2006.00469.x","article-title":"Comparison of the effects of topical administration of a fixed combination of dorzolamide\u2013timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs","volume":"9","author":"Plummer","year":"2006","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0135","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0161-6420(98)91046-6","article-title":"A randomized trial comparing the dorzolamide\u2013timolol combination given twice daily to monotherapy with timolol and dorzolamide","volume":"105","author":"Boyle","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.06.001_b0140","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0161-6420(98)91047-8","article-title":"A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide\u2013timolol combination to monotherapy with timolol or dorzolamide","volume":"105","author":"Clineschmidt","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.06.001_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00055735-200404000-00013","article-title":"Fixed combinations of topical glaucoma medications","volume":"15","author":"Fechtner","year":"2004","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0150","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0161-6420(98)91045-4","article-title":"The efficacy and safety of the dorzolamide\u2014timolol combination versus the concomitant administration of its components","volume":"105","author":"Strohmaier","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.06.001_b0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/108076803321637618","article-title":"Comparison of the efficacy of the fixed-combination timolol\/dorzolamide versus concomitant administration of timolol and dorzolamide","volume":"19","author":"Bacharach","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2015.06.001_b0160","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00002512-200017060-00005","article-title":"Topical dorzolamide 2%\/timolol 0.5%","volume":"17","author":"Ormrod","year":"2000","journal-title":"Drug Aging"},{"key":"10.1016\/j.ejpb.2015.06.001_b0165","unstructured":"D.G. Kaplan, S. Pazirandeh, M.M. Alvarado, L. Attal, Process for Making Soft Contact and Intraocular Lenses with an Esterifiable Carboxyl-Containing Polymer, U.S. Patent 4,668,446 A, 1987."},{"key":"10.1016\/j.ejpb.2015.06.001_b0170","unstructured":"O. Wichterle, Method of manufacturing soft and flexible contact lenses, in: Google Patents, 1970."},{"key":"10.1016\/j.ejpb.2015.06.001_b0175","unstructured":"D.G. Vanderlaan, D.C. Turner, M.V. Hargiss, A.C. Maiden, R.N. Love, J.D. Ford, F.F. Molock, R.B. Steffen, G.A. Hill, A. Alli, Soft Contact Lenses, U.S. Patent 6,943,203 B2, 2005."},{"key":"10.1016\/j.ejpb.2015.06.001_b0180","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/S0142-9612(01)00164-8","article-title":"A novel phosphorylcholine-coated contact lens for extended wear use","volume":"22","author":"Willis","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.06.001_b0185","first-page":"205","article-title":"Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels","volume":"353","author":"Kim","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.06.001_b0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00004397-198902930-00002","article-title":"Systemic adverse reactions to glaucoma medications","volume":"29","author":"Fraunfelder","year":"1989","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.ejpb.2015.06.001_b0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/jop.1987.3.177","article-title":"Systemic side effects from ophthalmic timolol and their prevention","volume":"3","author":"Fraunfelder","year":"1987","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2015.06.001_b0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00608402","article-title":"Timolol pharmacokinetics and effects on heart rate and blood pressure after acute and chronic administration","volume":"16","author":"Bobik","year":"1979","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0090-9556(25)05750-2","article-title":"Physiological disposition and metabolism of timolol in man and laboratory animals","volume":"3","author":"Tocco","year":"1975","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2015.06.001_b0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2125.1985.tb02651.x","article-title":"Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics","volume":"19","author":"Lewis","year":"1985","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0215","first-page":"1621","article-title":"Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans","volume":"40","author":"Schmitz","year":"1999","journal-title":"Invest. Ophth. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.06.001_b0220","series-title":"Eye Irritation in Dermatotoxicology and Pharmacology","author":"McDonald","year":"1977"},{"key":"10.1016\/j.ejpb.2015.06.001_b0225","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"Orzalesi","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.06.001_b0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1444-0938.2009.00370.x","article-title":"A medical device\/drug delivery system for treatment of glaucoma","volume":"92","author":"Schultz","year":"2009","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.ejpb.2015.06.001_b0235","first-page":"79","article-title":"Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma","volume":"95","author":"Hillman","year":"1975","journal-title":"Trans. Ophthal. Soc. UK"},{"key":"10.1016\/j.ejpb.2015.06.001_b0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.58.7.674","article-title":"Management of acute glaucoma with pilocarpine-soaked hydrophilic lens","volume":"58","author":"Hillman","year":"1974","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bjo.72.2.150","article-title":"Drug delivery through soft contact lenses","volume":"72","author":"Jain","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-104-2-197","article-title":"Cardiovascular effects of ophthalmic timolol","volume":"104","author":"Leier","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejpb.2015.06.001_b0255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0002-9394(01)01181-3","article-title":"Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma","volume":"132","author":"Dickstein","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0260","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.06.001_b0265","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2460\/ajvr.1991.52.03.432","article-title":"Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs","volume":"52","author":"Wilkie","year":"1991","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ejpb.2015.06.001_b0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archopht.1977.04450040071009","article-title":"Timolol: dose response and duration of action","volume":"95","author":"Zimmerman","year":"1977","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0275","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archopht.1977.04450040067008","article-title":"Timolol: a \u03b2-adrenergic blocking agent for the treatment of glaucoma","volume":"95","author":"Zimmerman","year":"1977","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0280","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s11095-012-0824-3","article-title":"Penetration of fluorescein across the rabbit cornea from the endothelial surface","volume":"29","author":"Gupta","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.06.001_b0285","first-page":"584","article-title":"Importance of the noncorneal absorption route in topical ophthalmic drug delivery","volume":"26","author":"Ahmed","year":"1985","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.06.001_b0290","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S0039-6257(99)00014-4","article-title":"Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy","volume":"43","author":"Sponsel","year":"1999","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.06.001_b0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog. Retin. Eye Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111500260X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111500260X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:25:06Z","timestamp":1748431506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111500260X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":59,"alternative-id":["S093964111500260X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.06.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}